RECENTLY PUBLISHED STUDIES ON GADOLINIUM AND NSF
The number of studies that have linked gadolinium-based contrast agents (GBCAs) to the development of NSF among some patients is growing. The FDA has published lists of research related to Gadolinium and NSF:
April 2006: Case report published in Nephrology Dialysis Transplantation medical journal regarding a possible link between GBCAs and NSF. Advance Access - January 23, 2006. (Grobner et al, Nephrol Dial Transplant 2006; Vol 21 (4):1104 1108. Erratum 2006 Jun;21(6):1745.)
May 29, 2006: Press release from the Danish Medicines Agency (DMA) about 25 reported cases of NSF among patients who had been exposed to Omniscan, a gadolinium contrast dye.
August 2, 2006: Study results published in the Journal of American Society of Nephrology found that gadolinium dye Omniscan triggers NSF. Retrospective study of about 370 patients with severe renal insufficiency using Omniscan estimated the risk of NSF to be 4%. (Marckmann et al, J Am Soc Nephrol 2006; 17: 2359 2362.)
November 13, 2006 (online) & January 2007 (print): Case study published in the Journal of the American Academy of Dermatology finds gadolinium in the tissue of NSF patients. (High et al, J Am Acad Dermatol 2007; 56 (1): 21 26.)
February 7, 2007: Study results published in the Clinical Journal of the American Society of Nephrology showed that exposure to GBCAs created a "highly significant" risk for NSF in patients with end-stage renal disease. (Deo et al, Clin J Am Soc Nephrol 2: 264 267, 2007.)
February 12, 2007 (online) & April 2007 (print): Research Letter published in the Journal of the American Academy of Dermatology shares study results linking gadolinium to NSF. (High et al, J Am Acad Dermatol 2007; 56 (4): 710-712.)
February 23, 2007: Study results published in the Morbidity and Mortality Weekly Report of the Center for Disease Control (CDC) showed that exposure to GBCAs was independently associated with nephrogenic fibrosing dermopathy (NFD). (MMWR 2007; 56(07):137 141.)
Contact Colorado Gadolinium Attorney, Beth Klein for help with your case
If you or someone you know has developed NSF or NFD symptoms after having an MRI or MRA, contact our firm for a FREE EVALUATION by one of our lead attorneys and consulting physician.
Our firm represents people across the country who have been injured by gadolinium contrast dyes. It is a key commitment of this firm to establish and maintain a close attorney client relationship with all of our clients. We want to be able to spend significant time with our clients and their families so that we can fully represent them and give them their voice in their cases. These cases are about their lives, their hope, their sorrow and loss, and their opportunity for healing and justice. We hope we can help you.
Free Case Evaluation for gadolinium contrast dye victims.
We will listen, and we will do what we can to help.
Copyright © 2007 Lawcolorado.net. All rights reserved |